Anticoagulant

Results: 549



#Item
31Abstract #: 281  M-ONC 402-a non anticoagulant low molecular weight heparin inhibits tumor metastasis He Zhou, Nancy Dussault, Edward Cochran, Rain Kwan, Juliane Karlgren, Marishka Barnes, Sucharita Roy, Radouane Zouaoui

Abstract #: 281 M-ONC 402-a non anticoagulant low molecular weight heparin inhibits tumor metastasis He Zhou, Nancy Dussault, Edward Cochran, Rain Kwan, Juliane Karlgren, Marishka Barnes, Sucharita Roy, Radouane Zouaoui

Add to Reading List

Source URL: www.momentapharma.com

Language: English - Date: 2012-06-27 14:59:09
32Protecting yourself  Staying informed The anticoagulant Xarelto®

Protecting yourself Staying informed The anticoagulant Xarelto®

Add to Reading List

Source URL: healthcare.bayer.com

Language: English - Date: 2014-04-22 04:22:01
    33Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

    Add to Reading List

    Source URL: www.momentapharma.com

    Language: English - Date: 2012-06-27 14:59:07
    34Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

    Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

    Add to Reading List

    Source URL: www.momentapharma.com

    Language: English - Date: 2012-06-27 15:00:31
    35Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

    Add to Reading List

    Source URL: www.momentapharma.com

    Language: English - Date: 2012-06-27 15:02:02
    36Abstract # 5005  M-ONC 402, a novel non-anticoagulant heparin, inhibits P-Selectin function and metastatic seeding of tumor cells in mice  Chia Lin Chu, Jay Duffner, Nancy Dussault, Alison Long, Sucharita Roy, Radouane Z

    Abstract # 5005 M-ONC 402, a novel non-anticoagulant heparin, inhibits P-Selectin function and metastatic seeding of tumor cells in mice Chia Lin Chu, Jay Duffner, Nancy Dussault, Alison Long, Sucharita Roy, Radouane Z

    Add to Reading List

    Source URL: www.momentapharma.com

    Language: English - Date: 2012-06-27 15:01:56
    37HAZARD NOTICE By arrangement with the Scottish Government Health Directorates UNIPATH SMARTCHECK INR BLOOD COAGULATION TEST SYSTEM: PRODUCT RECALL

    HAZARD NOTICE By arrangement with the Scottish Government Health Directorates UNIPATH SMARTCHECK INR BLOOD COAGULATION TEST SYSTEM: PRODUCT RECALL

    Add to Reading List

    Source URL: www.hfs.scot.nhs.uk

    Language: English
    38Remote Monitoring // CASE STUDY  Optimizing Anticoagulant Therapy Management: Roche’s Bold Connected Solution We believe the addition of mobile technology and cloud-based connectivity is a natural evolution for point-o

    Remote Monitoring // CASE STUDY Optimizing Anticoagulant Therapy Management: Roche’s Bold Connected Solution We believe the addition of mobile technology and cloud-based connectivity is a natural evolution for point-o

    Add to Reading List

    Source URL: www.qualcommlife.com

    Language: English - Date: 2015-04-11 23:13:21
    39Pharmaceutical Management Agency  Annual Review 2011 Highlights

    Pharmaceutical Management Agency Annual Review 2011 Highlights

    Add to Reading List

    Source URL: www.pharmac.govt.nz

    Language: English - Date: 2012-02-29 07:00:03
    40NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Atrial Fibrillation

    NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Atrial Fibrillation

    Add to Reading List

    Source URL: www.nice.org.uk

    Language: English - Date: 2014-07-30 06:27:48